COMMUNIQUÉS West-GlobeNewswire

LifeStance to Host Second Quarter 2025 Earnings Conference Call on August 7, 2025
17/07/2025
SCOTTSDALE, Ariz., July 17, 2025 (GLOBE NEWSWIRE) -- LifeStance Health Group, Inc. (NASDAQ: LFST), one of the nation’s largest providers of outpatient mental health care, will issue its second quarter 2025 earnings [...]
Hapbee Announces Insider Purchase of $1 Million USD via Closing of Non-Brokered Private Placement
17/07/2025
Follows Prior Investment by Jaylen Brown and the New Leadership Team Underscoring Growing Confidence in Hapbee VANCOUVER, British Columbia, July 17, 2025 (GLOBE NEWSWIRE) -- Hapbee Technologies, Inc. (TSXV: HAPB | OTCID [...]
Omada Health to Announce Second Quarter 2025 Financial Results and Host Conference Call on August 7, 2025
17/07/2025
SAN FRANCISCO, July 17, 2025 (GLOBE NEWSWIRE) -- Omada Health (Nasdaq: OMDA), the virtual between-visit healthcare provider, today announced that it will release its second quarter 2025 results on Thursday, August 7, [...]
Basel Medical Group Putting On Hold On The Acquisition of BTC Digital Asset
17/07/2025
Singapore, July 17, 2025 (GLOBE NEWSWIRE) -- Basel Medical Group Ltd (Nasdaq: BMGL or the “Company”) , today announced that it is putting on hold on the acquisition of BTC digital asset. After thorough discussions, [...]
Globus Medical Schedules Second Quarter Earnings Release and Conference Call
17/07/2025
AUDUBON, Pa., July 17, 2025 (GLOBE NEWSWIRE) -- Globus Medical , Inc. (NYSE:GMED), a leading musculoskeletal technology company, will announce its financial results for the second quarter ended June 30, 2025 after the [...]
Advancing Preventive Vascular Inflammation in the South with SmartVascular Dx™ Test
17/07/2025
IRVINE, Calif., July 17, 2025 (GLOBE NEWSWIRE) -- MorningStar Laboratories, LLC ., (“MSL” or “the Company”), a leading developer of precision diagnostic tests that address unmet clinical needs, is proud to announce the [...]
FOXO TECHNOLOGIES INC. ANNOUNCES REVERSE STOCK SPLIT
17/07/2025
WEST PALM BEACH, FLORIDA, July 17, 2025 (GLOBE NEWSWIRE) -- FOXO Technologies Inc. (NYSE American: FOXO) (“FOXO” or the “ Company ”), today announced that its Board of Directors has approved a 1 for 1.99 reverse stock [...]
Ontario Health Coalition and Health Coalitions from across Canada issued a joint statement in advance of the gathering of First Ministers and the Council of the Federation:
18/07/2025
Any governments across Canada that claim to prioritize the economy while dismantling our public health care have lost their moral compass TORONTO, July 17, 2025 (GLOBE NEWSWIRE) -- The Ontario Health Coalition and [...]
OSE Immunotherapeutics lance une Newsletter pour les investisseurs individuels
17/07/2025
OSE Immunotherapeutics lance une Newsletter pour les investisseurs individuels NANTES, France, 17 juillet 2025, 18h30 – OSE Immunotherapeutics SA (ISIN: FR0012127173; Mnemo: OSE) , société de biotechnologie qui [...]
OSE Immunotherapeutics lance une Newsletter pour les investisseurs individuels
17/07/2025
OSE Immunotherapeutics Launches Newsletter for Individual Shareholders NANTES, France, July 17, 2025, 6:30pm CET – OSE Immunotherapeutics SA (ISIN: FR0012127173; Mnemo: OSE) , a biotech company dedicated to developing [...]
Heartflow Unveils Landmark DECIDE Registry Data Demonstrating Impact of Heartflow Plaque Analysis on Coronary Artery Disease Medical Management
17/07/2025
More than 50% of patients saw treatment changes following Heartflow Plaque Analysis – driving promising LDL cholesterol improvements and individualized care MONTREAL, July 17, 2025 (GLOBE NEWSWIRE) -- Heartflow, Inc. , [...]
Health care advocates afraid of major cuts and privatization hold shadow summit and rally at Council of the Federation next week
17/07/2025
HUNTSVILLE, Ontario, July 17, 2025 (GLOBE NEWSWIRE) -- Outside the Council of the Federation and the gathering of First Ministers, public health care advocates from across Canada will be joining a shadow summit, rally, [...]
Creative Medical Technology Holdings Receives Notice of Allowance for the Prevention and/or Treatment of Type 1 Diabetes Using Modulated Immune Cells
17/07/2025
PHOENIX, July 17, 2025 (GLOBE NEWSWIRE) -- Creative Medical Technology Holdings, Inc. (NASDAQ: CELZ) (“Creative Medical” or the “Company”) , a clinical-stage biotechnology company specializing in regenerative medicine, [...]
Tevogen Signs Letter of Intent for New In-House Cell Therapy Manufacturing Facility
17/07/2025
WARREN, N.J., July 17, 2025 (GLOBE NEWSWIRE) -- Tevogen (“Tevogen Bio Holdings Inc.” or “Company”) (Nasdaq: TVGN ) today announced the signing of a letter of intent to lease a 17,428-square-foot facility in New Jersey. [...]
Biotricity Delivers Strong Fiscal Year 2025 Results with Revenue Growth, Continued Margin Improvement, and Reduced Operating Expenses, Putting Profitability within Reach
17/07/2025
FY25 revenue up 14.3% YOY FY25 margins improvement of 8.9% to 76.6%, from 69.3% in the prior year; Q4-FY25 margins improved to 80.4% as margin expansion forecasted to continue FY25 operating expenses lower by 24.5% YOY [...]
SPR to Feature Five Abstracts on SPRINT® PNS at ASPN 2025
17/07/2025
- Data on chronic postoperative knee pain to be highlighted as a top abstract along with a first-ever look at SPRINT PNS in patients with migraine pain - CLEVELAND, July 17, 2025 (GLOBE NEWSWIRE) -- Leading pain [...]
Professional Credit Renews HFMA Peer Review Designation
17/07/2025
CHICAGO, July 17, 2025 (GLOBE NEWSWIRE) -- The Healthcare Financial Management Association (HFMA) today announced that, following rigorous review, Professional Credit has once again achieved the “Peer Reviewed by HFMA [...]
AI-Supported, Single-Center Cancer Model from Liv Hospital
17/07/2025
Photo: Liv Hospital via FL Communications ISTANBUL, July 17, 2025 (GLOBE NEWSWIRE) -- The “single-center oncology model,” implemented by only a select number of institutions worldwide, is being carried out with advanced [...]
Oncotelic Therapeutics Highlights Peer‑Reviewed Publication Linking TGFB2 to Survival in Younger Pancreatic Cancer Patients
17/07/2025
Data support further evaluation of investigational antisense OT‑101 (trabedersen) as a TGFB2‑targeted approach in pancreatic ductal adenocarcinoma (PDAC). AGOURA HILLS, Calif., July 17, 2025 (GLOBE NEWSWIRE) -- [...]

Pages